Kay, Lynn Swanson, MA, CCC-SLP - Speech-Language Pathologist in Arvada, CO

Kay, Lynn Swanson, MA, CCC-SLP is a Speech-language Pathologist based in Arvada, Colorado. Kay, Lynn Swanson is licensed to practice in Colorado (license number 00926675) and her current practice location is 7015 Nile Ct, Arvada, Colorado. She can be reached at her office (for appointments etc.) via phone at (303) 503-3742.

NPI number for Kay, Lynn Swanson is 1013423706 and her current mailing address is 7015 Nile Ct, Arvada, Colorado. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013423706.

Contact Information

Kay, Lynn Swanson, MA, CCC-SLP
7015 Nile Ct,
Arvada, CO 80007-7049
(303) 503-3742
Not Available



Healthcare Provider's Profile

Full NameKay, Lynn Swanson
GenderFemale
SpecialitySpeech-language Pathologist
Location7015 Nile Ct, Arvada, Colorado
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1013423706
  • Provider Enumeration Date: 12/18/2017
  • Last Update Date: 03/17/2018

Medical Identifiers

Medical identifiers for Kay, Lynn Swanson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013423706NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 00926675 (Colorado)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kay, Lynn Swanson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kay, Lynn Swanson, MA, CCC-SLP
7015 Nile Ct,
Arvada, CO 80007-7049

Ph: (303) 503-3742
Kay, Lynn Swanson, MA, CCC-SLP
7015 Nile Ct,
Arvada, CO 80007-7049

Ph: (303) 503-3742

News Archive

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Results of a prospective, randomized trial indicate that when treating femoral artery (SFA) lesions, the Zilver PTX Paclitaxel-Eluting Stent shows sustained effectiveness compared to percutaneous transluminal angioplasty, even in diabetic patients.

Alnylam defends against Tekmira complaint, files answer and counterclaim

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, has filed an answer and counterclaim to a complaint filed by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court.

Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases

Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.

Self-care techniques should be first line of treatment for patients with facial pain, suggests study

While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.

Revolutions Medical reworks exclusive license with Traxyz for breast biopsy localization system

Revolutions Medical Corporation recently completed the reworking of a worldwide exclusive license with Traxyz, LLC for an image guided navigation system to convert over 50,000 conventional mammography systems for use as a high accuracy breast biopsies system (BBS). This BBS facilitates accurate and fast non-palpable lesions and micro calcification localization in the treatment of breast cancer.

Read more News

› Verified 2 days ago


Speech-Language Pathologist in Arvada, CO

Serena Laughren, CCC-SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 9713 W 57th Pl, Arvada, CO 80002
Phone: 720-722-0411    
Caitlin Page,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 6616 Reed Ct, Arvada, CO 80003
Phone: 720-434-7777    
Mrs. Lisa Moore, M.A., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 9353 Iron Mountain Way, Arvada, CO 80007
Phone: 937-313-5347    
Clg Solutions Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 9090 Flora St, Arvada, CO 80005
Phone: 720-435-0350    
Speech Garden Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 9713 W 57th Pl, Arvada, CO 80002
Phone: 720-722-0411    
Carly Melissa Murray, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 8448 Otis Dr, Arvada, CO 80003
Phone: 303-570-3181    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.